APG-2449 in Patients With Advanced Solid Tumors

Clinical trial NCT03917043 · RECRUITING

Trial details

NCT number: NCT03917043
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Cancer Non Small Cell Lung Cancer Esophageal Cancer Ovarian Cancer Malignant Pleural Mesothelioma

Start date: 2019-05-27
Primary completion: 2027-12-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.